CRISPR Therapeutics AG - Company Profile
Powered by 
All the sales intelligence you need on CRISPR Therapeutics AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how CRISPR Therapeutics AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with CRISPR Therapeutics AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on CRISPR Therapeutics AG’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 01 Nov 2023 | CRISPR Therapeutics AG Enters Phase I Clinical Trial Agreement with Medpace Holdings Inc for CTX-320 (GDCT0501137) | Contract Service Agreement |
CRISPR Therapeutics AG
|
Medpace Holdings Inc |
| 31 Jul 2023 | CRISPR Therapeutics AG Enters Phase I Clinical Trial Agreement with Medpace Holdings Inc for CTX-310 (GDCT0493749) | Contract Service Agreement |
CRISPR Therapeutics AG
|
Medpace Holdings Inc |
| 27 Mar 2023 | Vertex Enters into Licensing Agreement with CRISPR Therapeutics | Licensing Agreement |
Vertex Pharmaceuticals Inc
|
CRISPR Therapeutics AG |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer